Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Siplizumab (TCD601) as Induction Therapy in Renal Transplant Recipients
NCT06365437Phase 2Terminated
- Sponsor
- ITB-MED
- Start
- Jun 2021
- Primary completion
- Dec 2024
- Countries
- 3
01
Overview
A Phase 2 trial of siplizumab in kidney transplantation, sponsored by ITB-MED. Started Jun 2021; status: terminated.
02
Drugs
siplizumab
03
Conditions
kidney transplantation
Beyond the preview
Go deeper on NCT06365437.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06365437.